Probability and predictors of treatment-seeking for prescription opioid use disorders: A National Study

Drug and Alcohol Dependence

Volumn 131, Issue 1-3, 2013, Pages 143-148

  Blanco, Carlos ^a   Iza, Miren ^a   Schwartz, Robert P ^b   Rafful, Claudia ^a   Wang, Shuai ^a   Olfson, Mark ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b FRIENDS RESEARCH INSTITUTE   (United States)

Author keywords

Comorbidity; Prescription opioid use disorders; Substance use disorders; Treatment seeking

Indexed keywords

OPIATE; PRESCRIPTION DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DEMOGRAPHY; DSM-IV; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; OPIATE ADDICTION; PERSONALITY DISORDER; PHOBIA; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; SOCIAL ASPECT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PRESCRIPTION DRUGS; PROBABILITY; SELF REPORT; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

CANNABIS;

EID: 84878553824     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.12.013     Document Type: Article

References (62)

1. Adamson J., Ben-Shlomo Y., Chaturvedi N., Donovan J. Ethnicity, socio-economic position and gender - do they affect reported health-care seeking behaviour?. Soc. Sci. Med. 2003, 57:895-904.
2. Alegria M., Canino G., Rios R., Vera M., Calderon J., Rusch D., Ortega A.N. Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatr. Serv. 2002, 53:1547-1555.
3. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. Washington, DC.
4. Angst M.S., Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104:570-587.
5. Ballantyne J.C. Opioid analgesia: perspectives on right use and utility. Pain Physician 2007, 10:479-491.
6. Birnbaum H.G., White A.G., Schiller M., Waldman T., Cleveland J.M., Roland C.L. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011, 12:657-667.
7. Blanco C., Alderson D., Ogburn E., Grant B.F., Nunes E.V., Hatzenbuehler M.L., Hasin D.S. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007, 90:252-260.
8. Blanco C., Secades-Villa R., Garcia-Rodriguez O., Labrador-Mendez M., Wang S., Schwartz R.P. Probability and predictors of remission from life-time prescription drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Psychiatr. Res. 2012, [epub ahead of print].
9. Bohnert A.S., Valenstein M., Bair M.J., Ganoczy D., McCarthy J.F., Ilgen M.A., Blow F.C. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011, 305:1315-1321.
10. Chatterji S., Saunders J.B., Vrasti R., Grant B.F., Hasin D., Mager D. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule - Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997, 47:171-185.
11. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., Donovan M.I., Fishbain D.A., Foley K.M., Fudin J., Gilson A.M., Kelter A., Mauskop A., O'Connor P.G., Passik S.D., Pasternak G.W., Portenoy R.K., Rich B.A., Roberts R.G., Todd K.H., Miaskowski C. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain 2009, 10:113-130.
12. Chu L.F., Angst M.S., Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin. J. Pain 2008, 24:479-496.
13. Cicero T.J., Inciardi J.A. Diversion and abuse of methadone prescribed for pain management. JAMA 2005, 293:297-298.
14. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2007, 64:566-576.
15. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
16. Cottler L.B., Grant B.F., Blaine J., Mavreas V., Pull C., Hasin D., Compton W.M., Rubio-Stipec M., Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997, 47:195-205.
17. Fenton M.C., Keyes K.M., Martins S.S., Hasin D.S. The role of a prescription in anxiety medication use, abuse, and dependence. Am. J. Psychiatry 2010, 167:1247-1253.
18. Fossati A., Barratt E.S., Borroni S., Villa D., Grazioli F., Maffei C. Impulsivity, aggressiveness, and DSM-IV personality disorders. Psychiatry Res. 2007, 149:157-167.
19. Gibbie T.M., Hides L.M., Cotton S.M., Lubman D.I., Aitken C., Hellard M. The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users. Med. J. Aust. 2011, 195:S16-S21.
20. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71:7-16.
21. Grant B.F., Goldstein R.B., Chou S.P., Huang B., Stinson F.S., Dawson D.A., Saha T.D., Smith S.M., Pulay A.J., Pickering R.P., Ruan W.J., Compton W.M. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry 2009, 14:1051-1066.
22. Grant B.F., Harford T.C., Dawson D.A., Chou P.S., Pickering R.P. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995, 39:37-44.
23. Grant B.F., Dawson D.A., Hasin D.S. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version 2007, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
24. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J., Pickering R.P. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 2004, 65:948-958.
25. Grant, B.F., Kaplan, K.K., Stinson, F.S., 2005. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. National Institute on Alcohol Abuse and Alcoholism, Bethesda.
26. Grant B.F., Kaplan K., Stinson F.S. Source and Accuracy Statement: The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions 2007, National Institute on Alcohol Abuse and Alcoholism, Bethesda.
27. Grant B.F., MooreT.Shepard J., Kaplan K. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 2007, National Institute on Alcohol Abuse and Alcoholism, Bethesda.
28. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
29. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J. Co-occurrence of DSM-IV personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr. Psychiatry 2005, 46:1-5.
30. Hasin D., Carpenter K.M., McCloud S., Smith M., Grant B.F. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997, 44:133-141.
31. Howard M.M., Weiler R.M., Haddox J.D. Development and reliability of items measuring the nonmedical use of prescription drugs for the Youth Risk Behavior Survey: results from an initial pilot test. J. Sch. Health 2009, 79:554-560.
32. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., Smith S.M., Goldstein R.B., Grant B.F. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2006, 67:1062-1073.
33. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Leon A.C., Solomon D.A., Coryell W., Maser J.D., Keller M.B. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch. Gen. Psychiatry 2005, 62:1322-1330.
34. Kessler R.C., Aguilar-Gaxiola S., Berglund P.A., Caraveo-Anduaga J.J., DeWit D.J., Greenfield S.F., Kolody B., Olfson M., Vega W.A. Patterns and predictors of treatment seeking after onset of a substance use disorder. Arch. Gen. Psychiatry 2001, 58:1065-1071.
35. Kessler R.C., Olfson M., Berglund P.A. Patterns and predictors of treatment contact after first onset of psychiatric disorders. Am. J. Psychiatry 1998, 155:62-69.
36. Kessler R.C., Ormel J., Petukhova M., McLaughlin K.A., Green J.G., Russo L.J., Stein D.J., Zaslavsky A.M., Aguilar-Gaxiola S., Alonso J., Andrade L., Benjet C., de Girolamo G., de Graaf R., Demyttenaere K., Fayyad J., Haro J.M., Hu C., Karam A., Lee S., Lepine J.P., Matchsinger H., Mihaescu-Pintia C., Posada-Villa J., Sagar R., Ustun T.B. Development of lifetime comorbidity in the World Health Organization World Mental Health Surveys. Arch. Gen. Psychiatry 2011, 68:90-100.
37. Kirana P.S., Rosen R., Hatzichristou D. Subjective well-being as a determinant of individuals' responses to symptoms: a biopsychosocial perspective. Int. J. Clin. Pract. 2009, 63:1435-1445.
38. Kuehn B.M. Scientists, officials eye tools aimed at combating abuse of painkillers. JAMA 2012, 307:19-21.
39. Lopez-Quintero C., Hasin D.S., de Los Cobos J.P., Pines A., Wang S., Grant B.F., Blanco C. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction 2011, 106:657-669.
40. Lopez-Quintero C., Perez de los Cobos J., Hasin D.S., Okuda M., Wang S., Grant B.F., Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011, 115:120-130.
41. Manchikanti L., Abdi S., Atluri S., Balog C.C., Benyamin R.M., Boswell M.V., Brown K.R., Bruel B.M., Bryce D.A., Burks P.A., Burton A.W., Calodney A.K., Caraway D.L., Cash K.A., Christo P.J., Damron K.S., Datta S., Deer T.R., Diwan S., Eriator I., Falco F.J., Fellows B., Geffert S., Gharibo C.G., Glaser S.E., Grider J.S., Hameed H., Hameed M., Hansen H., Harned M.E., Hayek S.M., Helm S., Hirsch J.A., Janata J.W., Kaye A.D., Kaye A.M., Kloth D.S., Koyyalagunta D., Lee M., Malla Y., Manchikanti K.N., McManus C.D., Pampati V., Parr A.T., Pasupuleti R., Patel V.B., Sehgal N., Silverman S.M., Singh V., Smith H.S., Snook L.T., Solanki D.R., Tracy D.H., Vallejo R., Wargo B.W. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2 - guidance. Pain Physician 2012, 15:S67-S116.
42. Martins S.S., Fenton M.C., Keyes K.M., Blanco C., Zhu H., Storr C.L. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol. Med. 2012, 42:1261-1272.
43. McCabe S.E. Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of U.S. college students. Drug Alcohol Depend. 2005, 79:53-62.
44. Meltzer E.C., Rybin D., Saitz R., Samet J.H., Schwartz S.L., Butler S.F., Liebschutz J.M. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain 2011, 152:397-402.
45. Mojtabai R., Olfson M., Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch. Gen. Psychiatry 2002, 59:77-84.
46. Olfson M., Kessler R.C., Berglund P.A., Lin E. Psychiatric disorder onset and first treatment contact in the United States and Ontario. Am. J. Psychiatry 1998, 155:1415-1422.
47. Olfson M., Liu S.M., Grant B.F., Blanco C. Influence of comorbid mental disorders on time to seeking treatment for major depressive disorder. Med. Care 2012, 50:227-232.
48. Perron B.E., Mowbray O.P., Glass J.E., Delva J., Vaughn M.G., Howard M.O. Differences in service utilization and barriers among Blacks, Hispanics, and Whites with drug use disorders. Subst. Abuse Treat. Prev. Policy 2009, 4:3.
49. Pickles A., Pickering K., Simonoff E., Silberg J., Meyer J., Maes H. Genetic clocks " and soft" events: a twin model for pubertal development and other recalled sequences of developmental milestones, transitions, or ages at onset. Behav. Genet. 1998, 28:243-253.
50. Rigg K.K., Ibanez G.E. Motivations for non-medical prescription drug use: a mixed methods analysis. J. Subst. Abuse Treat. 2000, 39:236-247.
51. Rogler L.H., Cortes D.E. Help-seeking pathways: a unifying concept in mental health care. Am. J. Psychiatry 1993, 150:554-561.
52. Ruan W.J., Goldstein R.B., Chou S.P., Smith S.M., Saha T.D., Pickering R.P., Dawson D.A., Huang B., Stinson F.S., Grant B.F. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008, 92:27-36.
53. Subramaniam G.A., Stitzer M.A. Clinical characteristics of treatment-seeking prescription opioid versus heroin using adolescents with opioid use disorder. Drug Alcohol Depend. 2009, 101:13-19.
54. Trescot A.M., Boswell M.V., Atluri S.L., Hansen H.C., Deer T.R., Abdi S., Jasper J.F., Singh V., Jordan A.E., Johnson B.W., Cicala R.S., Dunbar E.E., Helm S., Varley K.G., Suchdev P.K., Swicegood J.R., Calodney A.K., Ogoke B.A., Minore W.S., Manchikanti L. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006, 9:1-39.
55. Trescot A.M., Helm S., Hansen H., Benyamin R., Glaser S.E., Adlaka R., Patel S., Manchikanti L. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008, 11:S5-S62.
56. Tse S.S., Walsh A.E. How does work work for people with bipolar affective disorder?. Occup. Ther. Int. 2001, 8:210-225.
57. Vaingankar, J.A., Rekhi, G., Subramaniam, M., Abdin, E., Chong, S.A. Age of onset of life-time mental disorders and treatment contact. Soc. Psychiatr. Epidemiol., in press.
58. Wang P.S., Berglund P., Olfson M., Pincus H.A., Wells K.B., Kessler R.C. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:603-613.
59. Wang P.S., Berglund P.A., Olfson M., Kessler R.C. Delays in initial treatment contact after first onset of a mental disorder. Health Serv. Res. 2004, 39:393-415.
60. Weiss R.D., Potter J.S., Provost S.E., Huang Z., Jacobs P., Hasson A., Lindblad R., Connery H.S., Prather K., Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp. Clin. Trials 2010, 31:189-199.
61. White A.G., Birnbaum H.G., Mareva M.N., Daher M., Vallow S., Schein J., Katz N. Direct costs of opioid abuse in an insured population in the United States. J. Manag. Care Pharm. 2005, 11:469-479.
62. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003, 69:215-232.